PL2644189T3 - Stabilne formulacje bortezomibu - Google Patents

Stabilne formulacje bortezomibu

Info

Publication number: PL2644189T3
Authority: PL; Poland
Prior art keywords: stable; bortezomib formulations; formulations; stable bortezomib; bortezomib
Prior art date: 2012-03-27

Application number

PL12183276T

Other languages

English (en)

Other versions

PL2644189T4 (pl

Inventor

Kumaresh Soppimath

Satish Pejaver

Kanaiyalal R Patel

Lakkaraju Dasaradhi

Rama Sodum

Hari Desu

Navneet Puri

Original Assignee

Innopharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-03-27

Filing date

2012-09-06

Publication date

2014-12-31

2012-03-27 Priority claimed from US13/431,313 external-priority patent/US8263578B2/en

2012-09-06 Application filed by Innopharma Inc filed Critical Innopharma Inc

2014-12-31 Publication of PL2644189T3 publication Critical patent/PL2644189T3/pl

2015-04-30 Publication of PL2644189T4 publication Critical patent/PL2644189T4/pl

Links

GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 title 1
229960001467 bortezomib Drugs 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Oncology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL12183276T 2012-03-27 2012-09-06 Stabilne formulacje bortezomibu PL2644189T4 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13/431,313 US8263578B2 (en)	2010-03-18	2012-03-27	Stable bortezomib formulations
EP12183276.0A EP2644189B1 (en)	2012-03-27	2012-09-06	Stable bortezomib formulations

Publications (2)

Publication Number	Publication Date
PL2644189T3 true PL2644189T3 (pl)	2014-12-31
PL2644189T4 PL2644189T4 (pl)	2015-04-30

Family

ID=46832244

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12183276T PL2644189T4 (pl)	2012-03-27	2012-09-06	Stabilne formulacje bortezomibu

Country Status (9)

Country	Link
EP (1)	EP2644189B1 (pl)
JP (1)	JP5774561B2 (pl)
CA (1)	CA2784240C (pl)
CY (1)	CY1115552T1 (pl)
DK (1)	DK2644189T3 (pl)
ES (1)	ES2497665T3 (pl)
PL (1)	PL2644189T4 (pl)
PT (1)	PT2644189E (pl)
SI (1)	SI2644189T1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2013227219A1 (en)	2012-03-02	2014-10-23	Dr. Reddy's Laboratories Limited	Pharmaceutical compositions comprising boronic acid compounds
US20170143622A1 (en) *	2014-07-04	2017-05-25	Dr. Reddy's Laboratories Limited	Stable liquid ready-to-use injectable formulation of bortezomib
EP3120836A1 (de) *	2015-07-22	2017-01-25	Stada Arzneimittel Ag	Gebrauchsfertige bortezomib-lösung
EP3120837A1 (de) *	2015-07-22	2017-01-25	Stada Arzneimittel Ag	Verfahren zur herstellung einer bortezomibester-lösung
KR101807462B1 (ko)	2017-03-09	2017-12-08	씨제이헬스케어 주식회사	보르테조밉을 포함하는 안정한 제제 및 이의 제조방법
CN109320584A (zh) *	2017-08-01	2019-02-12	重庆医药工业研究院有限责任公司	一种硼替佐米的杂质及其制备方法
JP7036602B2 (ja) *	2018-01-18	2022-03-15	日本化薬株式会社	ボルテゾミブを含有する医薬製剤の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
CA2435146C (en)	2001-01-25	2011-03-29	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Formulation of boronic acid compounds
CA2667348A1 (en) *	2006-11-03	2008-05-15	University Of Maryland, Baltimore	Methods of using saha and bortezomib for treating multiple myeloma
WO2008075376A1 (en)	2006-12-18	2008-06-26	Natco Pharma Limited	Polymorphic forms of bortezomib and process for their preparation
SI2318419T2 (sl)	2008-06-17	2025-10-30	Takeda Pharmaceutical Company Limited	Spojine boronat estra in njihovi farmacevtski sestavki
WO2010039762A2 (en)	2008-10-01	2010-04-08	Dr. Reddy's Laboratories Ltd.	Pharmaceutical compositions comprising boronic acid compounds
KR20110114562A (ko)	2009-01-09	2011-10-19	썬 파마 어드밴스트 리서치 컴패니 리미티드	보르테조밉 함유 약학적 조성물
EP2238973A1 (en) *	2009-04-07	2010-10-13	Cephalon France	Lyophilized preparations of proteasome inhibitors
RU2529800C2 (ru) *	2010-03-18	2014-09-27	ИННОФАРМА, Инк.	Стабильные составы бортезомиба

2012
- 2012-07-27 CA CA2784240A patent/CA2784240C/en not_active Expired - Fee Related
- 2012-08-23 JP JP2012184022A patent/JP5774561B2/ja not_active Expired - Fee Related
- 2012-09-06 SI SI201230066T patent/SI2644189T1/sl unknown
- 2012-09-06 PL PL12183276T patent/PL2644189T4/pl unknown
- 2012-09-06 EP EP12183276.0A patent/EP2644189B1/en active Active
- 2012-09-06 ES ES12183276.0T patent/ES2497665T3/es active Active
- 2012-09-06 PT PT121832760T patent/PT2644189E/pt unknown
- 2012-09-06 DK DK12183276.0T patent/DK2644189T3/da active
2014
- 2014-08-14 CY CY20141100654T patent/CY1115552T1/el unknown

Also Published As

Publication number	Publication date
SI2644189T1 (sl)	2014-10-30
ES2497665T3 (es)	2014-09-23
EP2644189B1 (en)	2014-05-14
PL2644189T4 (pl)	2015-04-30
CA2784240A1 (en)	2013-09-27
JP5774561B2 (ja)	2015-09-09
JP2013203738A (ja)	2013-10-07
EP2644189A1 (en)	2013-10-02
DK2644189T3 (da)	2014-08-18
CY1115552T1 (el)	2017-01-04
PT2644189E (pt)	2014-08-29
CA2784240C (en)	2014-07-08

Publication	Publication Date	Title
EP2547333A4 (en)	2014-04-30	STABLE BORTEZOMIB FORMULATIONS
ZA201500212B (en)	2017-04-26	Progesterone formulations
HUE045652T2 (hu)	2020-01-28	Antitest-készítmények
SI2877155T1 (sl)	2021-04-30	Opioidne formulacije
ZA201407373B (en)	2016-10-26	Novel pharmaceutical formulations
IL236304A0 (en)	2015-02-26	Formulations for diclofenac
IL289157A (en)	2022-02-01	Opioid compounds
ZA201306000B (en)	2014-04-30	Stable formulation
GB201220354D0 (en)	2012-12-26	Dermal compositions
ZA201407677B (en)	2016-05-25	Nicotine formulation
PT2644189E (pt)	2014-08-29	Formulações estáveis de bortezomib
SG11201406097SA (en)	2014-11-27	Capsule formulation
GB201210530D0 (en)	2012-07-25	Extended release formulations
ZA201408114B (en)	2016-08-31	Oral formulation
PL2908859T3 (pl)	2017-10-31	Formulacje arypiprazolu
ZA201406407B (en)	2016-01-27	Pharmaceutical formulation containing flupirtin
GB201221125D0 (en)	2013-01-09	Pharmaceutial formulations
GB201206178D0 (en)	2012-05-23	Formulations
GB201211406D0 (en)	2012-08-08	Pharmaceutical formulations
GB201211403D0 (en)	2012-08-08	Pharmaceutical formulations
IL234771A0 (en)	2014-11-30	Nicotine formulation
GB201211247D0 (en)	2012-08-08	Improved formulation
GB201103769D0 (en)	2011-04-20	Cosmetic formulations
GB201103767D0 (en)	2011-04-20	Cosmetic formulations